Cepheid Asks Federal Court to Rule Two Roche PCR Patents Invalid
August 28, 2012
Cepheid Asks Federal Court to Rule Two Roche PCR Patents Invalid
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- In Cepheid v. Roche IP Suit, Court Delays Hearing on One Patent, Dismisses Second Patent from Case
January 18, 2013 / GenomeWeb Daily News - JP Morgan Healthcare Conference, Day Two: Life Technologies, Roche, Agilent, Thermo Fisher, Cepheid, GenMark
January 9, 2013 / GenomeWeb Daily News - Report Values Global MDx Market at $11B by 2015; Projects qPCR to Remain Key Driver
February 16, 2012 / PCR Insider - As FDA's 2009 H1N1 EUAs Expire, PCR Test Makers Refine Plans for Next Flu Season
July 1, 2010 / PCR Insider - FDA Approves Roche Test as CDx for Tarceva for Treating Certain NSCLC Patients
May 15, 2013 / GenomeWeb Daily News